Skip to main content
Caplight Logo









Gelita AG

Gelita AG

Eberbachgelita.com

Overview

Gelita AG is a global manufacturer of collagen proteins, gelatin, and collagen peptides for the food, health, nutrition, and pharmaceutical industries that occasionally engages in corporate strategic investments.

Year Founded

1875

Portfolio Companies

1

Website

gelita.com

Investments

Gelita AG investments
CompanyDateStageLead
GeltorJul 2020Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Gelita AG based?

Gelita AG is headquartered in Eberbach, Germany.

When was Gelita AG founded?

Gelita AG was founded in 1875.

How many portfolio companies does Gelita AG have?

Gelita AG has 1 portfolio company in Caplight's dataset.

What are some companies in Gelita AG's portfolio?

Portfolio companies visible on Caplight include Geltor.

What was Gelita AG's most recent investment shown here?

Gelita AG's most recent investment in this portfolio sample was in Geltor in 2020.

What sectors does Gelita AG focus on?

Gelita AG focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does Gelita AG focus on?

Gelita AG typically invests at the Early stage.

Firmographic Details

HeadquartersEberbach
Year Founded1875

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?